{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:51:46Z","timestamp":1790380306556,"version":"4.1.0"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>The Farnesoid X receptor (FXR) is a nuclear receptor which is activated by bile acids. Bile acids function in solubilization of dietary fats and vitamins in the intestine. In addition, bile acids have been increasingly recognized to act as signaling molecules involved in energy metabolism pathways, amongst others <jats:italic>via<\/jats:italic> activating FXR. Upon activation by bile acids, FXR controls the expression of many genes involved in bile acid, lipid, glucose and amino acid metabolism. An inability to properly use and store energy substrates may predispose to metabolic disorders, such as obesity, diabetes, cholestasis and non-alcoholic fatty liver disease. These diseases arise through a complex interplay between genetics, environment and nutrition. Due to its function in metabolism, FXR is an attractive treatment target for these disorders. The regulation of FXR expression and activity occurs both at the transcriptional and at the post-transcriptional level. It has been shown that FXR can be phosphorylated, SUMOylated and acetylated, amongst other modifications, and that these modifications have functional consequences for DNA and ligand binding, heterodimerization and subcellular localization of FXR. In addition, these post-translational modifications may selectively increase or decrease transcription of certain target genes. In this review, we provide an overview of the posttranslational modifications of FXR and discuss their potential involvement in cholestatic and metabolic disorders.<\/jats:p>","DOI":"10.3389\/fendo.2021.729828","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T15:14:05Z","timestamp":1632755645000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Post-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders"],"prefix":"10.3389","volume":"12","author":[{"given":"Monique D.","family":"Appelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne W.","family":"van der Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia W. C.","family":"van Mil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90530-8","article-title":"Identification of a Nuclear Receptor That Is Activated by Farnesol Metabolites","volume":"81","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a Nuclear Receptor for Bile Acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile Acids: Natural Ligands for an Orphan Nuclear Receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.23.3.864-872.2003","article-title":"Identification of Farnesoid X Receptor Beta as a Novel Mammalian Nuclear Receptor Sensing Lanosterol","volume":"23","author":"Otte","year":"2003","journal-title":"Mol Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/pro.3496","article-title":"The Nuclear Receptor Superfamily: A Structural Perspective","volume":"27","author":"Weikum","year":"2018","journal-title":"Protein Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.004188","article-title":"Structural Insights Into the Heterodimeric Complex of the Nuclear Receptors FXR and RXR","volume":"293","author":"Zheng","year":"2018","journal-title":"J Biol Chem"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209505200","article-title":"Natural Structural Variants of the Nuclear Receptor Farnesoid X Receptor Affect Transcriptional Activation","volume":"278","author":"Zhang","year":"2003","journal-title":"J Biol Chem"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.07.022","article-title":"Differential Activation of the Human Farnesoid X Receptor Depends on the Pattern of Expressed Isoforms and the Bile Acid Pool Composition","volume":"86","author":"Vaquero","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"166183","DOI":"10.1016\/j.bbadis.2021.166183","article-title":"Splice Variants of Metabolic Nuclear Receptors: Relevance for Metabolic Disease and Therapeutic Targeting","volume":"1867","author":"Mukha","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0378-1119(02)00557-7","article-title":"Generation of Multiple Farnesoid-X-Receptor Isoforms Through the Use of Alternative Promoters","volume":"290","author":"Huber","year":"2002","journal-title":"Gene"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241100-00005","article-title":"Enterohepatic Circulation: Physiological, Pharmacokinetic and Clinical Implications","volume":"41","author":"Roberts","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31651","article-title":"Targeting the Four Pillars of Enterohepatic Bile Salt Cycling; Lessons From Genetics and Pharmacology","volume":"73","author":"Kunst","year":"2020","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1152\/physrev.00049.2019","article-title":"Molecular Physiology of Bile Acid Signaling in Health, Disease, and Aging","volume":"101","author":"Perino","year":"2021","journal-title":"Physiol Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.44.070175.001313","article-title":"Bile Acid Metabolism","volume":"44","author":"Danielsson","year":"1975","journal-title":"Annu Rev Biochem"},{"key":"B15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/hep.22627","article-title":"Bile Acids Activate Fibroblast Growth Factor 19 Signaling in Human Hepatocytes to Inhibit Cholesterol 7alpha-Hydroxylase Gene Expression","volume":"49","author":"Song","year":"2009","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A Regulatory Cascade of the Nuclear Receptors FXR, SHP-1, and LRH-1 Represses Bile Acid Biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.31724","article-title":"Farnesoid X Receptor and Bile Salts Are Involved in Transcriptional Regulation of the Gene Encoding the Human Bile Salt Export Pump","volume":"35","author":"Plass","year":"2002","journal-title":"Hepatology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00430.2005","article-title":"The Nuclear Receptor for Bile Acids, FXR, Transactivates Human Organic Solute Transporter-Alpha and -Beta Genes","volume":"290","author":"Landrier","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29251","article-title":"Hepatic Uptake of Conjugated Bile Acids Is Mediated by Both Sodium Taurocholate Cotransporting Polypeptide and Organic Anion Transporting Polypeptides and Modulated by Intestinal Sensing of Plasma Bile Acid Levels in Mice","volume":"66","author":"Slijepcevic","year":"2017","journal-title":"Hepatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M207903200","article-title":"Liver Receptor Homologue-1 Mediates Species- and Cell Line-Specific Bile Acid-Dependent Negative Feedback Regulation of the Apical Sodium-Dependent Bile Acid Transporter","volume":"278","author":"Chen","year":"2003","journal-title":"J Biol Chem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2005.03.019","article-title":"Regulation of Ileal Bile Acid-Binding Protein Expression in Caco-2 Cells by Ursodeoxycholic Acid: Role of the Farnesoid X Receptor","volume":"69","author":"Campana","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810223391707","article-title":"Molecular Pathogenesis of Cholestasis","volume":"339","author":"Trauner","year":"1998","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2018.12.018","article-title":"Developments in Bile Salt Based Therapies: A Critical Overview","volume":"161","author":"Donkers","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1021\/jm025529g","article-title":"6alpha-Ethyl-Chenodeoxycholic Acid (6-ECDCA), A Potent and Selective FXR Agonist Endowed With Anticholestatic Activity","volume":"45","author":"Pellicciari","year":"2002","journal-title":"J Med Chem"},{"key":"B25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bbadis.2017.10.003","article-title":"Farnesoid X Receptor: A \"Homeostat\" for Hepatic Nutrient Metabolism","volume":"1864","author":"Massafra","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22519","article-title":"Farnesoid X Receptor Antagonizes Nuclear Factor kappaB in Hepatic Inflammatory Response","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80726-6","article-title":"A Unified Nomenclature System for the Nuclear Receptor Superfamily","volume":"97","year":"1999","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic Fatty Liver Disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/science.1204265","article-title":"Human Fatty Liver Disease: Old Questions and New Insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201545502","article-title":"The \u201cBig Bang\u201d in Obese Fat: Events Initiating Obesity-Induced Adipose Tissue Inflammation","volume":"45","author":"Wensveen","year":"2015","journal-title":"Eur J Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1159\/000450909","article-title":"Farnesoid X Receptor an Emerging Target to Combat Obesity","volume":"35","author":"De Magalhaes Filho","year":"2017","journal-title":"Dig Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.taap.2014.12.005","article-title":"Individual Bile Acids Have Differential Effects on Bile Acid Signaling in Mice","volume":"283","author":"Song","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(03)00112-6","article-title":"Structural Basis for Bile Acid Binding and Activation of the Nuclear Receptor FXR","volume":"11","author":"Mi","year":"2003","journal-title":"Mol Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(03)00104-7","article-title":"A Chemical, Genetic, and Structural Analysis of the Nuclear Bile Acid Receptor FXR","volume":"11","author":"Downes","year":"2003","journal-title":"Mol Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.004652","article-title":"Ligand Binding and Heterodimerization With Retinoid X Receptor Alpha (RXRalpha) Induce Farnesoid X Receptor (FXR) Conformational Changes Affecting Coactivator Binding","volume":"293","author":"Wang","year":"2018","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg569","article-title":"Structure of the Heterodimeric Ecdysone Receptor DNA-Binding Complex","volume":"22","author":"Devarakonda","year":"2003","journal-title":"EMBO J"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1053\/j.gastro.2020.07.036","article-title":"FXR Isoforms Control Different Metabolic Functions in Liver Cells via Binding to Specific DNA Motifs","volume":"159","author":"Ramos Pittol","year":"2020","journal-title":"Gastroenterology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X Receptor Activation Inhibits Inflammation and Preserves the Intestinal Barrier in Inflammatory Bowel Disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/me.2008-0092","article-title":"Phosphorylation of Farnesoid X Receptor by Protein Kinase C Promotes Its Transcriptional Activity","volume":"22","author":"Gineste","year":"2008","journal-title":"Mol Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cmet.2009.09.009","article-title":"FXR Acetylation Is Normally Dynamically Regulated by P300 and SIRT1 But Constitutively Elevated in Metabolic Disease States","volume":"10","author":"Kemper","year":"2009","journal-title":"Cell Metab"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201489527","article-title":"A Dysregulated Acetyl\/SUMO Switch of FXR Promotes Hepatic Inflammation in Obesity","volume":"34","author":"Kim","year":"2015","journal-title":"EMBO J"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.443937","article-title":"SUMOylation of the Farnesoid X Receptor (FXR) Regulates the Expression of FXR Target Genes","volume":"288","author":"Balasubramaniyan","year":"2013","journal-title":"J Biol Chem"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00441.2011","article-title":"Direct Methylation of FXR by Set7\/9, A Lysine Methyltransferase, Regulates the Expression of FXR Target Genes","volume":"302","author":"Balasubramaniyan","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26710","article-title":"Glucose Sensing O-GlcNAcylation Pathway Regulates the Nuclear Bile Acid Receptor Farnesoid X Receptor (FXR)","volume":"59","author":"Berrabah","year":"2014","journal-title":"Hepatology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60761-738-9_15","article-title":"Phosphorylation Control of Nuclear Receptors","volume":"647","author":"Lalevee","year":"2010","journal-title":"Methods Mol Biol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1038\/s41467-018-04697-5","article-title":"Postprandial FGF19-Induced Phosphorylation by Src Is Critical for FXR Function in Bile Acid Homeostasis","volume":"9","author":"Byun","year":"2018","journal-title":"Nat Commun"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00346.2005","article-title":"Bile Acids Stimulate PKCalpha Autophosphorylation and Activation: Role in the Attenuation of Prostaglandin E1-Induced cAMP Production in Human Dermal Fibroblasts","volume":"291","author":"Le","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)30029-8","article-title":"Activation of Protein Kinase C Alpha and Delta by Bile Acids: Correlation With Bile Acid Structure and Diacylglycerol Formation","volume":"38","author":"Rao","year":"1997","journal-title":"J Lipid Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8613063","article-title":"Tauroursodeoxycholic Acid Activates Protein Kinase C in Isolated Rat Hepatocytes","volume":"110","author":"Beuers","year":"1996","journal-title":"Gastroenterology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1995.268.2.G300","article-title":"Ursodeoxycholic Acid Inhibits Glucagon-Induced cAMP Formation in Hamster Hepatocytes: A Role for PKC","volume":"268","author":"Bouscarel","year":"1995","journal-title":"Am J Physiol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1210\/me.2016-1105","article-title":"Phosphorylation of Farnesoid X Receptor at Serine 154 Links Ligand Activation With Degradation","volume":"30","author":"Hashiguchi","year":"2016","journal-title":"Mol Endocrinol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1172\/JCI68815","article-title":"Metformin Interferes With Bile Acid Homeostasis Through AMPK-FXR Crosstalk","volume":"124","author":"Lien","year":"2014","journal-title":"J Clin Invest"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1038\/emm.2016.81","article-title":"Regulation and Function of AMPK in Physiology and Diseases","volume":"48","author":"Jeon","year":"2016","journal-title":"Exp Mol Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22431","article-title":"The Membrane Protein ATPase Class I Type 8B Member 1 Signals Through Protein Kinase C Zeta to Activate the Farnesoid X Receptor","volume":"48","author":"Frankenberg","year":"2008","journal-title":"Hepatology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"eaat6662","DOI":"10.1126\/scisignal.aat6662","article-title":"Activation of Atypical Protein Kinase C by Sphingosine 1-Phosphate Revealed by an aPKC-Specific Activity Reporter","volume":"12","author":"Kajimoto","year":"2019","journal-title":"Sci Signal"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21950","article-title":"ATP8B1 Requires an Accessory Protein for Endoplasmic Reticulum Exit and Plasma Membrane Lipid Flippase Activity","volume":"47","author":"Paulusma","year":"2008","journal-title":"Hepatology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e04-07-0589","article-title":"Distinct In Vivo Dynamics of Vertebrate SUMO Paralogues","volume":"15","author":"Ayaydin","year":"2004","journal-title":"Mol Biol Cell"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M104214200","article-title":"Polymeric Chains of SUMO-2 and SUMO-3 Are Conjugated to Protein Substrates by SAE1\/SAE2 and Ubc9","volume":"276","author":"Tatham","year":"2001","journal-title":"J Biol Chem"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2010.12.008","article-title":"Transcriptional Control of Metabolic and Inflammatory Pathways by Nuclear Receptor SUMOylation","volume":"1812","author":"Treuter","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00008.2014","article-title":"Neuronal SUMOylation: Mechanisms, Physiology, and Roles in Neuronal Dysfunction","volume":"94","author":"Henley","year":"2014","journal-title":"Physiol Rev"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3011","article-title":"The SUMO Pathway: Emerging Mechanisms That Shape Specificity, Conjugation and Recognition","volume":"11","author":"Gareau","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-061909-093311","article-title":"Sumoylation: A Regulatory Protein Modification in Health and Disease","volume":"82","author":"Flotho","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M009476200","article-title":"SUMO-1 Conjugation In Vivo Requires Both a Consensus Modification Motif and Nuclear Targeting","volume":"276","author":"Rodriguez","year":"2001","journal-title":"J Biol Chem"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1124\/mol.105.012104","article-title":"The Methyl Transferase PRMT1 Functions as Co-Activator of Farnesoid X Receptor (FXR)\/9-Cis Retinoid X Receptor and Regulates Transcription of FXR Responsive Genes","volume":"68","author":"Rizzo","year":"2005","journal-title":"Mol Pharmacol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1042\/BST0351405","article-title":"PIAS Proteins as Regulators of Small Ubiquitin-Related Modifier (SUMO) Modifications and Transcription","volume":"35","author":"Palvimo","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803978","article-title":"The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity","volume":"183","author":"Vavassori","year":"2009","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.06624-11","article-title":"Identification of Estrogen Receptor Beta as a SUMO-1 Target Reveals a Novel Phosphorylated Sumoylation Motif and Regulation by Glycogen Synthase Kinase 3beta","volume":"32","author":"Picard","year":"2012","journal-title":"Mol Cell Biol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/jmcb\/mjx009","article-title":"A CK2-RNF4 Interplay Coordinates Non-Canonical SUMOylation and Degradation of Nuclear Receptor FXR","volume":"9","author":"Bilodeau","year":"2017","journal-title":"J Mol Cell Biol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2016.06.007","article-title":"The World of Protein Acetylation","volume":"1864","author":"Drazic","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B71","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.gene.2005.09.010","article-title":"Acetylation and Deacetylation of Non-Histone Proteins","volume":"363","author":"Glozak","year":"2005","journal-title":"Gene"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201202056","article-title":"Mechanistic Insights Into the Regulation of Metabolic Enzymes by Acetylation","volume":"198","author":"Xiong","year":"2012","journal-title":"J Cell Biol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.07.002","article-title":"Lysine Acetylation: Codified Crosstalk With Other Posttranslational Modifications","volume":"31","author":"Yang","year":"2008","journal-title":"Mol Cell"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M803531200","article-title":"The P300 Acetylase Is Critical for Ligand-Activated Farnesoid X Receptor (FXR) Induction of SHP","volume":"283","author":"Fang","year":"2008","journal-title":"J Biol Chem"},{"key":"B75","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.celrep.2017.12.061","article-title":"A P300 and SIRT1 Regulated Acetylation Switch of C\/EBPalpha Controls Mitochondrial Function","volume":"22","author":"Zaini","year":"2018","journal-title":"Cell Rep"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.05988-11","article-title":"Hepatic Deletion of SIRT1 Decreases Hepatocyte Nuclear Factor 1alpha\/Farnesoid X Receptor Signaling and Induces Formation of Cholesterol Gallstones in Mice","volume":"32","author":"Purushotham","year":"2012","journal-title":"Mol Cell Biol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biophys.36.040306.132820","article-title":"Structural Mechanisms Underlying Posttranslational Modification by Ubiquitin-Like Proteins","volume":"36","author":"Dye","year":"2007","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1042\/BST0370937","article-title":"The Emerging Complexity of Protein Ubiquitination","volume":"37","author":"Komander","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M112.017905","article-title":"Proteomic Analyses Reveal Divergent Ubiquitylation Site Patterns in Murine Tissues","volume":"11","author":"Wagner","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"B80","first-page":"2015","article-title":"The O-GlcNAc Modification","volume-title":"Essentials of Glucobiology","author":"Hart","year":""},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-060608-102511","article-title":"Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic Disease","volume":"80","author":"Hart","year":"2011","journal-title":"Annu Rev Biochem"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)43295-9","article-title":"Topography and Polypeptide Distribution of Terminal N-Acetylglucosamine Residues on the Surfaces of Intact Lymphocytes. Evidence for O-Linked GlcNAc","volume":"259","author":"Torres","year":"1984","journal-title":"J Biol Chem"},{"key":"B83","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrm3915","article-title":"Non-Histone Protein Methylation as a Regulator of Cellular Signalling and Function","volume":"16","author":"Biggar","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb1045","article-title":"Structural Basis for the Methylation Site Specificity of SET7\/9","volume":"13","author":"Couture","year":"2006","journal-title":"Nat Struct Mol Biol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(03)64012-7","article-title":"Acetylation and Methylation in Nuclear Receptor Gene Activation","volume":"364","author":"Xu","year":"2003","journal-title":"Methods Enzymol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(01)00405-1","article-title":"Purification and Functional Characterization of a Histone H3-Lysine 4-Specific Methyltransferase","volume":"8","author":"Wang","year":"2001","journal-title":"Mol Cell"},{"key":"B87","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41467-019-14138-6","article-title":"SUMOylation Inhibitors Synergize With FXR Agonists in Combating Liver Fibrosis","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat Commun"},{"key":"B88","doi-asserted-by":"publisher","first-page":"13462","DOI":"10.1038\/srep13462","article-title":"Expression of Hepatic Fibroblast Growth Factor 19 Is Enhanced in Primary Biliary Cirrhosis and Correlates With Severity of the Disease","volume":"5","author":"Wunsch","year":"2015","journal-title":"Sci Rep"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-013-0892-0","article-title":"Epigenetic Histone Methylation Regulates Transforming Growth Factor Beta-1 Expression Following Bile Duct Ligation in Rats","volume":"49","author":"Sheen-Chen","year":"2014","journal-title":"J Gastroenterol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/hep.30275","article-title":"Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease","volume":"69","author":"Blokker","year":"2019","journal-title":"Hepatology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e00006-17","DOI":"10.1128\/MCB.00006-17","article-title":"Obesity-Linked Phosphorylation of SIRT1 by Casein Kinase 2 Inhibits Its Nuclear Localization and Promotes Fatty Liver","volume":"37","author":"Choi","year":"2017","journal-title":"Mol Cell Biol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0000000000000593","article-title":"Farnesoid X Receptor Expression Reduced in Obese Rat Model With Insulin Resistance","volume":"350","author":"Pang","year":"2015","journal-title":"Am J Med Sci"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.4.890","article-title":"Glucose Regulates the Expression of the Farnesoid X Receptor in Liver","volume":"53","author":"Duran-Sandoval","year":"2004","journal-title":"Diabetes"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)67706-9","article-title":"Discovery of a Metabolic Pathway Mediating Glucose-Induced Desensitization of the Glucose Transport System. Role of Hexosamine Biosynthesis in the Induction of Insulin Resistance","volume":"266","author":"Marshall","year":"1991","journal-title":"J Biol Chem"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1586\/14789450.2013.820536","article-title":"Protein O-GlcNAcylation in Diabetes and Diabetic Complications","volume":"10","author":"Ma","year":"2013","journal-title":"Expert Rev Proteomics"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01004-12","article-title":"Farnesoid X Receptor Inhibits the Transcriptional Activity of Carbohydrate Response Element Binding Protein in Human Hepatocytes","volume":"33","author":"Caron","year":"2013","journal-title":"Mol Cell Biol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2015.01.004","article-title":"Bile Acid Nuclear Receptor FXR and Digestive System Diseases","volume":"5","author":"Ding","year":"2015","journal-title":"Acta Pharm Sin B"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.729828\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T15:14:10Z","timestamp":1632755650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.729828\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,27]]},"references-count":97,"alternative-id":["10.3389\/fendo.2021.729828"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.729828","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,27]]},"article-number":"729828"}}